D. E. Shaw & Co., L.P. 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | Sarepta Therapeutics, Inc. SRPT | D. E. Shaw & Co., L.P. | 2,007,025 1.900% | -3,052,887 (-60.33%) | Filing |
| 2025-07-25 8:14 pm Unchanged | 2025-07-18 | 13G | Sarepta Therapeutics, Inc. SRPT | D. E. Shaw & Co., L.P. | 5,059,912 5.100% | 0 (Unchanged) | Filing |
| 2025-07-25 4:08 pm Purchase | 2025-07-18 | 13G | Sarepta Therapeutics, Inc. SRPT | D. E. Shaw & Co., L.P. | 5,059,912 5.100% | 5,059,912 (New Position) | Filing |